|
|
ViewRay is developing the Renaissance™ System 1000, which combines MRI and gamma ray radiotherapy to provide real-time beam-on imaging and targeting of tumors. MRI is the only imaging technology capable of producing a stream of dynamic images during radiation therapy which will not dose the patient with additional radiation.
Funders:
Orbimed, Fidelity BioSciences, Kearny Venture Partners, Ailsing Capital and Siemens Venture Capital
|
|
|